Sonia Ben-Yehuda

PeriGen, Inc. provides fetal monitoring solutions employing patented pattern-recognition and obstetric technology that empower perinatal clinicians to make confident and real-time decisions about the mothers and babies in their care. Its PeriGEn Visual Cueing enables users an instant view of the mother?s and baby?s current status and trends. The company was founded in 1995 and is headquartered in Princeton, NJ.

Advanticom, Inc. provides information technology solutions. It specializes in network infrastructure, network operating systems, unified communications, security and data center. The company was founded in 1998 and is headquartered in Pittsburgh, PA.

Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.

Siemens Financial Services, Inc. provides business-to-business financial solutions. It offers equipment, transport, and automobile leasing services. The firm serves energy, healthcare and infrastructure industries. The company was founded in 1997 and is headquartered in Iselin, NJ.

Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA.

GenomeDx, Inc. operates as a genomic information company developing solutions for prostate cancer treatment and the management of other urologic cancers. It offers Decipher and Guidance test. The company is headquartered in San Diego, CA.